Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Corporate News: Circus SE (EQS) +++ CIRCUS SE Aktie +3,59%

NANALYSIS Aktie

 >NANALYSIS Aktienkurs 
0.093 EUR    +5.7%    (TradegateBSX)
Ask: 0.101 EUR / 20640 Stück
Bid: 0.086 EUR / 24184 Stück
Tagesumsatz: 18000 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
NANALYSIS Aktie über LYNX handeln
>NANALYSIS Performance
1 Woche: +1,2%
1 Monat: -4,2%
3 Monate: -14,5%
6 Monate: -33,2%
1 Jahr: -50,4%
laufendes Jahr: -5,7%
>NANALYSIS Aktie
Name:  NANALYSIS SCIENTI
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA63000Y1034 / A2PNDW
Symbol/ Ticker:  1N1 (Frankfurt)
Kürzel:  FRA:1N1, ETR:1N1, 1N1:GR
Index:  -
Webseite:  http://www.nanalysis.com/
Profil:  Nanalysis Scientific Corp. is a scientific instrument manufacturer specializing in compact Nuclear Magnetic Resonance (NMR) spectrometers and analyzers for laboratory and industrial applications. The company produces portable devices like the NMReady..
>Volltext..
Marktkapitalisierung:  12.36 Mio. EUR
Unternehmenswert:  23.45 Mio. EUR
Umsatz:  25.67 Mio. EUR
EBITDA:  0.17 Mio. EUR
Nettogewinn:  -7.61 Mio. EUR
Gewinn je Aktie:  -0.07 EUR
Schulden:  11.53 Mio. EUR
Liquide Mittel:  0.25 Mio. EUR
Operativer Cashflow:  0.57 Mio. EUR
Bargeldquote:  0.02
Umsatzwachstum:  -10.52%
Gewinnwachstum:  -37.77%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  NANALYSIS
Letzte Datenerhebung:  09.04.26
>NANALYSIS Kennzahlen
Aktien/ Unternehmen:
Aktien: 138.45 Mio. St.
Frei handelbar: 96.3%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Strong buy
Kursziel: 195.63%
Bewertung:
KGV: -
KGV lG: -
KUV: 0.42
KBV: 1.8
PEG-Ratio: -0.03
EV/EBITDA: 141.24
Rentabilität:
Bruttomarge: 17.95%
Gewinnmarge: -29.66%
Operative Marge: -8.97%
Managementeffizenz:
Gesamtkaprendite: -28.57%
Eigenkaprendite: -73.23%
>NANALYSIS Peer Group
Gesundheit, Aromen & Duftstoffe, Cannabis- Produkte, Medizinprodukte & -technik/ Implantate/ Wundpflege, Agrochemie
 
08.04.26 - 23:27
Nanalysis Scientific Corp. reports Q4 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.04.26 - 22:18
Nanalysis Announces Fourth Quarter and Full Year 2025 Results (PR Newswire)
 
Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $1.2 Million Full Year Revenue of $40.1 Million and Adjusted EBITDA of $903 Thousand CALGARY, AB, April 8, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR......
04.03.26 - 23:03
Nanalysis Announces Grant of Options and Restricted Share Units (PR Newswire)
 
CALGARY, AB, March 4, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI) (FRA: 1N1) announces the Company's Board of Directors has granted 1,210,000 restricted share units ("RSUs") and 350,000 stock options ("Options") to certain directors, officers......
26.01.26 - 22:18
Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering (PR Newswire)
 
CALGARY, AB, Jan. 26, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce, further to its December 8, 2025 and December 23, 2025 news releases, that it has closed the second and final tranche the......
23.12.25 - 22:27
Nanalysis upsizes private placement, closes first tranche (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
23.12.25 - 22:18
Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche (PR Newswire)
 
CALGARY, AB, Dec. 23, 2025 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement of units (the "Offering"),......
08.12.25 - 14:03
Nanalysis Announces $2.5 Million Private Placement (PR Newswire)
 
CALGARY, AB, Dec. 8, 2025 /PRNewswire/ -Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering") of up to 16,666,667 units of the Company (the......
24.11.25 - 23:54
Nanalysis Scientific meldet Umsatzrückgang für Q3 2025 und setzt auf Neuausrichtung (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
24.11.25 - 23:00
Nanalysis Scientific Corp. reports Q3 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.11.25 - 22:54
Nanalysis Announces Third Quarter 2025 Results (PR Newswire)
 
CALGARY, AB, Nov. 24, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, announces third quarter results for the period ending on September......
14.11.25 - 14:03
Nanalysis Announces Change of Management (PR Newswire)
 
Not for distribution to U.S. newswire services or dissemination in the United States CALGARY, AB, Nov. 14, 2025 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), announces that Randall McRae has resigned as Chief Financial......
07.10.25 - 23:01
Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026 (PR Newswire)
 
CALGARY, AB, Oct. 7, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, announced......
03.09.25 - 14:15
Nanalysis Chosen by IMRIS as Critical Component MRI Supplier (PR Newswire)
 
CALGARY, AB, Sept. 3, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, has......
29.08.25 - 12:36
Nanalysis Scientific reports Q2 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.08.25 - 23:12
Nanalysis Announces Second Quarter 2025 Results (PR Newswire)
 
CALGARY, AB, Aug. 28, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces second quarter results for the period ending on June......
21.08.25 - 23:06
Nanalysis Announces Second Quarter 2025 Conference Call (PR Newswire)
 
Hosting Call at 5:00 pm ET on Thursday, August 28th European Q&A Session on Friday, August 29th at 8:30am ET CALGARY, AB, Aug. 21, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and imaging......
09.07.25 - 14:33
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro) (PR Newswire)
 
CALGARY, AB, July 9, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and MRI technology for industrial and research applications announces the publication in the National Formulary of the first......
06.06.25 - 16:39
Nanalysis announces note offering of $2 million (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.05.25 - 22:36
Nanalysis Scientific reports Q1 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.05.25 - 22:06
Nanalysis Announces First Quarter 2025 Results (PR Newswire)
 
Delivers Another Quarter of Positive Adjusted EBITDA & Operating Cash Flow CALGARY, AB, May 28, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wenn jedoch die Kraft, die die menschliche Aktivität bestimmt, nicht die Vernunft ist, bleibt der Mensch unter dem Niveau seiner eigenen Möglichkeiten. - Robert Strange McNamara
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!